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Abnormal expression of integrin oc6,B4 in cervical intraepithelial neoplasia
JD Aplin, S Dawson and MW Seif
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UK.
Summary We have used subunit-specific monoclonal antibodies (MAbs) and immunohistochemistry to
examine the distribution of integrin a6,B4 in normal ectocervical epithelium and various grades of cervical
intraepithelial neoplasia (CIN). Antibodies were first characterised by immunoprecipitation from two surface-
labelled tumour cell lines. Monoclonal antibody G71 was found to precipitate integrin (4 from BeWo but not
T47D cells, while other anti-04 antibodies precipitated (4 from both cell lines. Both G71 and an antiserum to
the C-terminal peptide of (34 precipitated free (4 from surface-iodinated BeWo cells. Neither antibody
recognised truncated (4 chains observed at approximately 160 kDa. These data suggest that different isoforms
of (34 are expressed in different tumour cell lines, and that there may be a pool of (4 at the cell surface that is
not complexed to a6. In normal cervix, both the a6 and P4 subunits occur at the basal surface of the basal cell
layer. In CIN, the distribution is markedly altered, with strong expression of a6 and (4 in the upper cell layers
of the ectocervical epithelium. All 40 cases of CIN that were studied exhibited this alteration. Furthermore, the
extent ofextrabasal staining appeared to correspond with the grade of CIN. The form ofintegrin (34 recognised
by antibody G71 also appears in the upper cell layers in CIN, but it shows a more restricted distribution than
the normal isoform.
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Integrins are a family of heterodimeric (ax,B) cell-surface
receptors involved in cell-matrix and cell-cell interactions
(Hynes, 1992). Integrin a6,B4 has been shown to be expressed
by many epithelial cells, usually at the basal cell surface at
the site of adhesion to the basement membrane (Sonnenberg
and Linders, 1990). Direct evidence for the involvement of
oc6,B4 in cell-basement membrane interaction has come from
tissues containing hemidesmosomes, in which it has been
demonstrated that a6,B4 is specifically localised within these
anchorage structures (Stepp et al., 1990; Sonnenberg et al.,
1991; Behzad et al., 1995). There is evidence that laminin
functions as a ligand for a6,B4 (De Luca et al., 1990; Lotz et
al., 1990; Lee et al., 1992; Niessen et al., 1994; Aplin and
Church, 1995). Mutations of the (34 subunit have been
observed in junctional epidermolysis bullosa, where there is
loss of dermal-epidermal adhesion (Phillips et al., 1994;
Vidal et al., 1995).
Cell surface molecules that mediate cell-cell or cell-
matrix adhesive interactions may be altered qualitatively or
quantitatively in carcinoma. Such alterations during neoplas-
tic transformation (Giancotti and Ruoslahti, 1990; Syming-
ton, 1990; Plantefaber and Hynes, 1989; Risinger et al., 1994;
Tidman et al., 1990) are coupled with the disruption of
basement membrane integrity and may occur as a
prerequisite of invasion into the underlying stroma (Liotta
et al., 1991; Frixen et al., 1991). Some of these changes are
likely to be detectable in preinvasive phases. Knowledge of
the altered adhesive properties oftransformed cells also offers
increased insight into the natural history of the disease
(Liotta et al., 1991; Giancotti and Ruoslahti, 1990;
Symington, 1990; Plantefaber and Hynes, 1989).
Invasive cervical cancer is preceded by a variable period of
intraepithelial neoplasia (CIN) thus providing an opportunity
to study neoplastic transformation in the preinvasive phase.
Here we describe the results of our investigation into the
behaviour of integrin a6(34 in CIN, where altered adhesive
properties are likely to be important in the development of
invasive cells.
Materials and methods
Cervical biopsies
Cervical biopsies (n =40) were selected from areas showing
abnormalities according to the standard colposcopic criteria of
the presence of acetowhite, iodine-negative lesions and
vascular abnormalities. Appropriate local ethical permission
was obtained. The biopsies were first washed in phosphate-
buffered saline (PBS), oriented correctly, then snap frozen
onto cryostat stubs in liquid nitrogen, using Optimal Cutting
Temperature Compound (OCT; Orme Scientific). They were
sectioned at right angles to the epithelial/stromal junction at
7 gm onto precleaned microscope slides (Taab) on a Reichart
Jung E cryostat and stored at -80°C until required. Normal
cervical tissues were obtained at hysterectomy from women
reported as having recent normal cytology. Initial histopatho-
logical assessment indicating normality or the presence ofCIN
and its grade was made on serial sections. The diagnosis was
later confirmed independently by another histopathologist
who screened the entire series.
Antibodies
Mouse monoclonal antibody (MAb) 5B5 to integrin #4 was
raised against amnion epithelial cells and had been previously
characterised by immunoprecipitation from ,B4-positive and
-negative cell lines (Sonnenberg et al., 1991; Aplin et al.,
1992). Mouse MAb G71 to integrin (4 was raised against
epithelial cells obtained from endometrial tissue (Aplin and
Seif, 1985; Aplin et al., 1992). Rat MAb GoH3 to integrin a6
(Sonnenberg and Linders, 1990) was a generous gift from Dr
Arnoud Sonnenberg, Amsterdam. Rat MAb 439-9B to
integrin P4 (Sonnenberg et al., 1991) was a kind gift from
Dr Steven Kennel, Oak Ridge, Tennessee. Monoclonal
antibodies were used as appropriately diluted hybridoma
supernatants.
Rabbit antiserum to integrin (34 was raised to the synthetic
peptide TLSTHMDQQFFQTC based on the cytoplasmic
carboxy terminal sequence of the molecule. This was
conjugated to rabbit serum albumin and used in repeated
subcutaneous injections. The serum was characterised by
ELISA on the peptide conjugate and Western blotting on the
intact subunit. It was then immunoaffinity purified for use in
immunoprecipitation.
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Human choriocarcinoma (BeWo) and breast carcinoma
(T47D) cells have been shown to express integrin subunits
on their cell surface and were used as controls. They were
grown in a 1:1 mixture of Ham's F12 and Dulbecco's
modified Eagle medium with 10% fetal calf serum (FCS),
Hepes, 2 mM L-glutamine, gentamycin and streptamycin.
BeWo human choriocarcinoma cells were grown to con-
fluency in Dulbecco's modified Eagle medium supplemented
with 10% FCS, glutamine and antibiotics. Cells were surface
labelled with 1251 (1 mCi per 10-7 cells) using lactoperoxidase/
hydrogen peroxide (Aplin et al., 1992) and lysed with 2%
Triton X100, 5 mg ml-' bovine serum albumin (BSA),
10 mg ml-' leupeptin and 2 mM phenylmethylsulphonyl
fluoride (PMSF) in PBS ABC (1 ml 10-7 cells). The resulting
lysate was precleared with protein A-Sepharose (Sigma),
preloaded with a similar Triton extract made using non-
radioactive cells. The supernatant was divided into aliquots
for immunoprecipitation; to 25 ml of antibody (GoH3, 5B5
and G71), 150 ml of iodinated cell extract was added in a
total volume of 200 ml in PBS ABC and the reaction mixture
incubated on ice for 1 h with periodic mixing. Immune
complexes were collected with protein A-Sepharose pre-
blocked with cold cell extract and preloaded with anti-
mouse immunoglobulin (Dako) at a concentration of 1 mg
IgG per ml of packed beads. This bead preparation, which is
loaded with anti-mouse IgG to only a fraction of its total
binding capacity, was used for both mouse and rabbit
primary antibodies; the latter, used as a polyclonal
preparation, binds avidly to unoccupied protein A. The
beads were washed six times with 1% Triton XI00 in PBS
ABC followed by a final wash in PBS ABC and boiled in gel
loading buffer for 10 min. Immunoprecipitates were analysed
by SDS-PAGE on 5% gels followed by autoradiography.
Immunohistochemistry
Stored, frozen sections of cervical tissue were brought to
room temperature and fixed in cold acetone for 10 min,
followed by washing in PBS. Endogenous peroxidase activity
was blocked for 60 min at 37°C (Andrew and Jasani, 1987).
Sections were then washed in PBS. All antibody incubations
were carried out for 60 min at room temperature, with three
5 min washes in PBS between stages. Primary antibody was
used at 1/25 (v/v) in PBS. Secondary antibody was
biotinylated rabbit anti-mouse (Dako) used at 1/300 (v/v).
A drop of avidin in complex with biotinylated peroxidase
(ABComplex/HRP; Dako) was then placed on the sections
and left for 30 min, rinsed off and washed as before. Bound
antibody was visualised by incubation in 3,3'-diaminobenzi-
dine (DAB) for 5-10 min (200 mg of DAB dissolved in
400 ml PBS, filtered, with the addition of 60 ml hydrogen
peroxide). After rinsing in running tap water, sections were
counterstained in Harris's haematoxylin (Sigma), dehydrated
and mounted in Hystomount (Taab). Appropriate controls
were included in each run.
Sections were graded for the extent of extrabasal staining.
H & E-stained consecutive sections were analysed and graded
independently for the extent of CIN by a histopathologist.
Results
Characterisation of antibodies by immunoprecipitation
Two carcinoma cell lines which express integrin a6/4 - BeWo
(Aplin et al., 1992) and T47D (Sonnenberg and Linders,
1990) - were selected for the characterisation of subunit-
specific monoclonal antibodies to be used in the study. Cell
surface iodination was carried out before immunoprecipita-
tion from detergent extracts under conditions expected to
preserve the association of integrins into heterodimeric
complexes. The anti-integrin a6 monoclonal antibody GoH3
precipitated from T47D cells the a6 subunit (120 kDa under
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reducing conditions) along with the 200 kDa ,B4 chain with
which it is associated (Figure 1, lane 1). In addition, a pair of
closely spaced bands was visible at approximately 160 kDa;
these are probably truncated forms of integrin ,B4 also found
in complex with ax6 (Falcioni et al., 1988; Kennel et al., 1989;
1 2 3 4 5 6
Figure 1 Immunoprecipitation of integrin a6,B4 from surface-
iodinated T47D cells. Lane 1, anti-a6 (GoH3); lane 2, anti-,B4
(439-9B); lane 3, control monoclonal antibody; lane 4, anti-,B4
(5B5); lane 5, control monoclonal antibody; lane 6, G71. Note
that GoH3, 439-9B and 5B5 all precipitate bands migrating in the
a6 and /34 positions, as well as truncated forms of /4. No
reactivity is detected in the G71 or control lanes. Markers, top to
bottom: full-length ,B4, two truncated ,B4 polypeptides, a6.
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Figure 2 Immunoprecipitation of integrin a6P4 from surface-
iodinated BeWo cells. Lane 1, anti-,B4 (G71); lane 2, control
monoclonal antibody; lane 3, anti-,84 (5B5); lane 4, anti-,B4 (439-
9B); lane 5, anti-a6 (GoH3). Note that G71 precipitates a band
comigrating with the /34 chain. 5B5, 439-9B and GoH3 all
precipitate ,B4, truncated forms of /4 and a6. Markers, top to
bottom: full length /34, two truncated ,B4 polypeptides, a6.Integrin x6f4 in CIN
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Figure 3 Immunoprecipitation of integrin a6,B4 from surface-
iodinated BeWo cells. Lane 1, anti-,B4 (G71); lane 2, anti-,B4 (5B5)
(underloaded); lane 3, anti-,B4 (439-9B); lane 4, control
monoclonal antibody; lane 5, rabbit polyclonal anti-,B4 peptide;
lane 6, control rabbit peptide; lane 7, anti-a6 (GoH3). Note that
G71 and the anti-,B4 polyclonal antiserum precipitate a 200kDa
band that comigrates with ,B4 precipitated by 439-9B and GoH3.
The polyclonal also precipitates a faster migrating complex of
bands, deduced to be N-terminally truncated ,B4 chains. Neither
G71 nor the anti-,B4 polyclonal antibody precipitates detectable
quantities of a6 subunit. Markers, top to bottom: full-length ,B4,
two truncated /34 polypeptides, a6.
Van Waes et al., 1991; Aplin et al., 1992; Giancotti et al.,
1992; Potts et al., 1994).
Antibody 439-9B to integrin /34 gave a similar pattern
(Figure 1, lane 2), though somewhat lower a6 subunit signal
intensity was detected. This suggested that, as previously
noted (Sonnenberg and Linders, 1990), a fraction of the pool
of integrin /4 at the surface of T47D cells may be
unassociated with a6, the anti-#4 precipitate thus containing
a lower abundance of a6. Antibody 5B5 to integrin /34 gave a
result identical to that obtained with 439-9B (Figure 1, lane
4) as previously reported (Sonnenberg et al., 1991). We were
unable to precipitate any polypeptide from T47D cells with
antibody G71 (Figure 1, lane 6).
BeWo cells were used to investigate further the properties
of G71. Very similar results were obtained when antibodies
GoH3, 439-9B and 5B5 were used in immunoprecipitation
from BeWo (Figure 2) and T47D (Figure 1) cells. Like T47D,
BeWo cells expressed an a6,B4 complex that could be
immunoprecipitated with either anti-a6 (GoH3: Figure 2,
lane 5) or anti-#4 (439-9B: Figure 2, lane 4; 5B5: Figure 2,
lane 3) antibodies. Truncated /34 chains were again present at
about 160 kDa in each case. Antibody G71 precipitated a
band that comigrated precisely with the full length /34 chain
(200 kDa), but neither a6 nor truncated /34 was detected in
this case (Figure 2, lane 1). To confirm that G71 was indeed
recognising the full length /4 chain, we compared its
behaviour in immunoprecipitation from BeWo cells with
that of a polyclonal antibody raised to an oligopeptide based
on the published C-terminal sequence (Hogervorst et al.,
1990; Suzuki and Naitoh, 1990; Tamura et al., 1990). The
anti-peptide serum immunoprecipitated the 200 kDa /34 chain
(Figure 3, lane 5), which comigrated precisely with the chain
precipitated by G71 (Figure 3, lane 1). The anti-peptide
serum also precipitated a doublet of bands at approximately
160 kDa (Figure 3, lane 5). These must be assumed to be N-
terminally truncated forms of /4, also reported by Giancotti
et al. (1992). The bands are substantially weaker than those
seen in this molecular weight range when 439-9B (Figure 3,
lane 3) or GoH3 (Figure 3, lane 7) were used, suggesting that
C-terminally truncated forms of /34 are also present (Falcioni
et al., 1988; Kennel et al., 1989; Van Waes et al., 1991;
Giancotti et al., 1992); these would not be recognised by the
peptide antiserum. Neither G71 nor the peptide antiserum
precipitated detectable quantities of the integrin a6 chain.
This suggests that free ,B4 is present at the BeWo cell surface,
and that both these antibodies preferentially recognise it.
The distribution of integrin oc6,B4 in cervical tissue
Monoclonal antibodies GoH3, G71 and 5B5 were used to
examine the distribution of integrin a6,B4 in normal and
neoplastic cervix. The expression of the ,B4 integrin subunit in
normal stratified squamous epithelium was monitored by
antibody 5B5. Expression was strongest at the basal aspect of
the basal cells (Figure 4a and b), with an accompanying
weaker pericellular and diffuse staining pattern in the basal
and parabasal layers (Figure 4b). The a6 subunit gave a
similar distribution (Figure 4c) as monitored by staining with
GoH3.
In cases of CIN (Figure 4d and e), staining with 5B5 and
GoH3 was seen on the surface of neoplastic cells which
displayed nuclear abnormalities, including an increased
nucleocytoplasmic ratio, nuclear hyperchromatism and the
presence of abnormal mitotic figures. In CIN I, in which
abnormal cells occupy the lower one-third of the epithelium,
staining with 5B5 extended beyond the basal region with
strong pericellular staining of the abnormal cells. In CIN II,
as the abnormal cells extend further through the epithelium
to occupy up to two-thirds of its thickness, staining with 5B5
and GoH3 followed suit. In CIN III, pericellular staining was
observed throughout the full thickness of epithelium though
there was some variation in its intensity (Figure 4d and e).
Altogether 40 cases of CIN were studied, and all of them
conformed to this pattern of staining.
Antibody G71 showed similar behaviour, with predomi-
nantly basal staining in the normal ectocervical epithelium
(Figure 5a). This antibody did not stain the lateral plasma
membranes or cytoplasmic regions of basal or parabasal cells.
The epitope was also present in the walls of small blood
vessels in the upper dermis (Figure 5a and b). G71 staining
was increasingly visible in the upper layers of the epithelium
with increasing grade of CIN (Figure Sb). Although G71-
positive cells could be observed throughout the epithelium in
CIN III, extrabasal staining was more heterogeneous and less
extensive than observed with 5B5 or GoH3, with G71-
negative cells always present in the lesion.
Discussion
Cervical cancer is one ofthe major health care issues affecting
women in the UK despite the proven success of screening
programmes for the preinvasive lesions (CIN) (Anderson et
al., 1988). The mechanisms that are involved in the
progression of intraepithelial neoplasia from in situ to
invasive phenotype remain poorly understood, but include
changes in cell adhesion, motility and proteolytic activity
leading to altered stability of the basement membrane
associated with penetration into the sublaminal matrix
(Liotta et al., 1991).
All available evidence indicates that the integrin /4
subunit forms heterodimeric complexes uniquely with
integrin a6 (Carter et al., 1990; De Luca et al., 1990; Lotz
et al., 1990; Sonnenberg and Linders, 1990; Sonnenberg et
al., 1991; Lee et al., 1992). However, in addition to its
heterodimeric form, integrin /34 has been suggested to exist at
the cell surface in a form uncomplexed to a chain
(Sonnenberg and Linders, 1990). Our data demonstrating
that anti-/34 antibodies 5B5 and 439-9B precipitate relatively
more labelled /34 and less a6 than does antibody GoH3 to the
x6 chain can be adduced in support of this suggestion, as can
the data of Hodivala et al. (1994) in cultured keratinocytes.
In normal cervix we have detected the a6 and #4 subunits
strongly at the basal cell surface, but also more weakly in the
cytoplasm and lateral plasma membrane domain of bothIntegrin A6fi4 in CIN
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Figure 4 Comparison of the distribution ofintegrin subunits ,B4 (antibody 5B5) and a6 (antibody GoH3) in normal cervix and CIN
III by immunoperoxidase histochemistry. (a, b) 5B5, normal cervix; (c) GoH3, normal cervix; (d) 5B5, CIN III; (e) GoH3, CIN III.
Note the strongly basal localisation of both subunits in normal tissue. In CIN III, both subunits show a pericellular pattern of
staining extending throughout the epithelium. Magnifications: a, x 80; b, c, x 160; d, e, x 475.
basal and parabasal cells. This distribution was also reported
by Carico et al. (1993) but it differs slightly from other
reports in which a basal-only pattern has been described
(Sonnenberg and Linders, 1990; Lee et al., 1992; Hughes et
al., 1994). The distinction is probably a result of the
combination of a high-affinity antibody with a highly
sensitive staining protocol, allowing the detection of smaller
quantities of antigen. All authors agree that the major
location of the a6,B4 complex is at the basal cell surface. In
comea (Stepp et al., 1990), skin (Sonnenberg et al., 1991) and
amnion (Behzad et al., 1995) it is known to be concentrated
specifically in hemidesmosomal junctions, where it is assumed
to have a role in anchoring the cell surface to the
extracellular matrix. Other normal epithelial cells that lack
hemidesmosomes also express a6,B4 basally (Sonnenberg and
Linders, 1990; Aplin, 1993).
The observation of a disrupted pattern of expression of
both a6 and /4 (and by inference, a6#4) in CIN confirms the
results reported by Carico et al. (1993) but we have used a
significantly larger study group (40 vs 13 respectively).
Hughes et al. (1994) reported similar findings in the context
of a larger panel of integrins. Our data are also consistent
with previous work indicating elevated levels of the ,B4
subunit in murine carcinoma (Falcioni et al., 1988; Kennel et
al., 1989; Van Waes et al., 1991), and with our previous
observation of increased expression in extrabasal locations in
squamous cell carcinoma of the skin (Tidman et al., 1990). In
contrast, Hodivala et al. (1994) reported a reduced level of
integrin a6#4 expression in HPV16/Ha-ras-transformed
keratinocytes and in a small group of HPV-positive CIN
lesions. In this context it will be of interest to correlate
further the behaviour of integrin a6#4 with HPV status in
CIN.
The onset of proliferative intraepithelial change implies
altered tissue kinetics with more rapid escape of neoplastic
cells from the basal layers of the tissue as well as loss ofIntegrin a6#4 in CIN
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Figure 5 Immunoperoxidase localisation of the G71 epitope in normal cervix (a) and CIN III (b). The basal localisation observed
in the normal tissue is largely consistent with that observed using other anti-,B4 antibodies, although no lateral staining is observed.
Note also that the epitope is detected in small blood vessels in the superficial dermis. In CIN III, staining in the basal layer is
somewhat weaker, but pericellular reactivity appears in upper cell layers within the lesion with considerable variation in reactivity
between individual cells. Magnification: x 495.
differentiated cells from intermediate and superficial layers.
This is likely to be accompanied by altered cell polarisation
and architecture, intercellular and cell-basement membrane
adhesive interactions (Liotta et al., 1991). The presence of /4-
containing cells in extrabasal layers of the neoplastic
epithelium could imply a more rapid escape from the basal
layer of cells bearing the residual hallmarks of the basal cell
phenotype, or alternatively it may be that integrin ,B4 is
capable of a function in intercellular organisation other than
adhesion to basement membrane. Loss ofhemidesmosomes is
a prerequisite of cell migration, either in wound healing
(Kurpakus, 1991) or tumour invasion (McNutt, 1976).
During trophoblast invasion loss of a6#4 occurs from the
migrating cell population soon after the loss of adhesion to
the villous basement membrane (Aplin, 1993); this contrasts
with the persistence ofa6#4 in cervical neoplastic cells in situ
as well as in invasive foci (Carico et al., 1993; Hughes et al.,
1994).
The properties of monoclonal antibodies 5B5 and 439-9B
show clearly that they recognise the extracellular domain of
integrin /4 (Sonnenberg et al., 1991) and immunoprecipitate
a6/34 complexes. In addition to the full length polypeptide,
these antibodies capture truncated forms of the ,B4 chain
present in both cell lines. The properties of these isoforms are
similar to those described previously for C-terminally
truncated /34 chains (Falcioni et al., 1988; Kennel et al.,
1989; Van Waes et al., 1991; Giancotti et al., 1992). These
can also be captured using antibody to a6, confirming their
ability to complex stably with a /4 chain. We cannot exclude
that some proteolysis of /34 occurred during our experiments
since calcium ions were present, and Giancotti et al. (1992)
have shown that the cytoplasmic domain of the subunit is
sensitive to a calcium-dependent protease, calpain. Their
evidence suggests that truncated forms of ,B4 are present
along with the full length chain in vivo. The immunopreci-
pitation analysis reported here, in which we have demon-
strated that G71 recognises a 200 kDa chain in BeWo cells
with precisely the same electrophoretic properties as one
recognised by a polyclonal antibody to the C-terminus of
human integrin /34, confirms previous evidence (Aplin et al.,
1992) that G71 recognises the integrin ,B4 subunit. In
contrast, no subunit was precipitated by G71 from T47D
cells in several different experiments. This suggests that
different /4 molecular isoforms may be present in different
cell types, not all of which are recognised by G71. The G71
epitope is in the extracellular domain of /4 as monitored by
light and electron microscopic immunolocalisation in normal
amnion epithelial cells (Aplin and Seif, 1985; JD Aplin and
DR Garrod, unpublished results). G71 recognises the full
length /34 subunit in preference to shorter variants suggesting
that its binding site may be near the amino terminus of the
molecule and therefore lost during N-terminal proteolytic
truncation.
It was therefore of interest to compare the distribution of
the G71 and 5B5 epitopes immunohistochemically. Differ-
ential expression of /4 isoforms may reflect the heterogeneity
of neoplastic cell behaviour and could be relevant to
pathophysiology of different phenotypes. The greater
heterogeneity of binding of G71 to neoplastic cells suggests
that a varying degree of proteolytic or other modification
may occur after escape from the basement membrane.
We have shown that a6#4 integrin displays an abnormal
distribution with remarkable consistency and in a fashion
that reflects the extent and grade of CIN. The appearance of
a6#4 in association with neoplastic cells suggests the
possibility that it may also occur in detectable quantities in
cervical smears. Our data support the view that the analysis
of molecular changes occurring in preinvasive conditions
offers the hope of improved basic understanding of the
disease process as well as the possibility of novel, and
perhaps more convenient, approaches to diagnosis.
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